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Abstract 
Background: Did the global financial crisis and its aftermath impact upon the performance of health 
systems in Europe? We investigated trends in amenable and other mortality in the EU since 2000 
across 28 EU countries. 
Methods: We use WHO detailed mortality files from 28 EU countries to calculate age-standardised 
deaths rates from amenable and other causes. We then use joinpoint regression to analyse trends in 
mortality before and after the onset of the economic crisis in Europe in 2008.  
Results: Amenable and other mortality have declined in the EU since 2000, albeit faster for 
amenable mortality. We observed increases in amenable mortality following the global financial 
crisis for females in Estonia (-4.53 annual percentage change (APC )in 2005-2012 to 0.03 APC in 
2012-2014) and Slovenia (4.22 APC in 2000-2013 to 0.73 in 2013-15) as well as males and females in 
Greece(males: -2.93 APC in 2000-2010 to 0.01 APC in 2010-2013; females: -3.48 APC in 2000-2010 to 
0.06 APC in 2010-2013). Other mortality continued to decline for these populations. Increases in 
deaths from infectious diseases before and after the crisis played a substantial part in reversals in 
Estonia, Slovenia and Greece.    
Conclusion: There is evidence that amenable mortality rose in Greece and, among females in Estonia 
and Slovenia. However, in most countries, trends in amenable mortality rates appeared to be 
unaffected by the crisis.  
Key words 
Amenable mortality, economic crisis, EU-28 
Page 1 of 17
http://mc.manuscriptcentral.com/ejph
Manuscripts submitted to European Journal of Public Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
Introduction  
The global financial crisis of 2007-08 and its consequences have had a severe long-term impact on 
many European economies. National economies, as measured by Gross Domestic Product (GDP), 
was most negatively affected in 2009, however some European Union (EU) member states, 
especially Greece, are yet to recover fully.
1
 Challenges arising from low or no economic growth, 
coupled with rising deficits and borrowing costs, impacted on the availability of resources for public 
spending, including for health, across Europe.
2
 Thus, per capita public spending on health fell in 
several countries, with a small number experiencing sustained reductions during 2009-2012, in 
particular Greece, Ireland and Slovenia, but also Italy, Portugal, Spain and the United Kingdom.
3
  The 
slowdown in health spending impacted upon the provision of health services 
4
 and access to care
5
, 
with large increases in unmet medical need observed in Greece, Estonia and Latvia during and 
following the crisis .
1
 Other evidence points to an increase in the proportion of European citizens 
aged 50 years and older who incurred a rise in out-of-pocket expenditures during the same time, 
with significant increases in the proportion of those experiencing catastrophic expenditures in the 
Czech Republic, Italy and Spain.
6
 It is plausible that these barriers to access impact health outcomes, 
while reduced public health spending may result in deterioration of quality of care. At the same 
time, a well-functioning and resilient health system should be capable of maintaining adequate 
levels of services, unless gaps in financing, coverage, or service delivery are unsurmountable.  
As was demonstrated previously
7-10
, European health systems have continued to contribute to 
improving population health by reducing deaths that can be avoided with timely and effective care 
(amenable mortality), a concept that is now used by several governments and international 
organisations as an indicator of health system performance.
11-15
  The pace of improvement varied 
across countries, reflecting differences in the availability of and access to technologies and 
treatment, the effectiveness of service delivery and wider healthcare policies. In this study we 
analyse amenable mortality trends from 2000 onwards in the countries of the European Union in 
order to understand the possible impacts of the global financial crisis by means of Joinpoint 
regression analysis. We contrast amenable deaths with those where healthcare may have a less 
obvious impact (other mortality).  
Methods 
Definition 
We used the list of conditions included in amenable mortality (AM) proposed by Nolte and McKee in 
2004 (Appendix 1).
7
 For consistency with previous work, we applied an upper age limit of 75 years 
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and include 50% of ischaemic heart disease deaths as potentially amenable. We also measured 
‘other’ mortality (all remaining causes) under age 75 year as a comparator to help interpret changes 
in amenable mortality.     
Data and availability 
We used the WHO detailed mortality files
16
 to obtain data on the number of deaths in the 28 EU 
member states by country, year, sex and cause by 5-year age-group and the corresponding 
population denominators, for the years 2000-2015. We calculated age-standardised mortality rates 
using the European Standard Population 2013. Mortality data for Italy (2004, 2005) and Portugal 
(2004-2006) were not available and we only calculated trends from 2006 and 2007, respectively. 
Data for Greece included a change in ICD-coding of cause of death in 2014 (from ICD-9 to ICD-10). 
This resulted in marked changes in certain causes of amenable death, so we only used data for 2000-
2013 to examine trends over time.  
Joinpoint regression 
We used Joinpoint regression analysis to identify significant changes in mortality trends for 
amenable and non-amenable (i.e. all other) causes in each EU country, starting in 2000. We then 
identified countries which experienced significant reversal (flat-lining or increase) in amenable 
mortality in either males or females in or after 2009, while mortality from other causes continued 
falling. While we recognise that economic crisis can also potentially affect mortality beyond 
amenable causes, trends in other causes provide a comparator between these two mortality groups, 
one of which is a widely recognised marker of health care sector performance.  We performed 
further Joinpoint analysis on specific amenable causes of death in those countries where we found 
reversals in trends. The overall change in trend was measured in terms of annual percentage change 
(APC). We used Joinpoint Trend Analysis Software v4.5.0.1.
17
  
 Pre- and post- crisis period 
The global financial crisis affected the economies of EU member states in or after 2008, with the 
earliest plausible impact on health service effectiveness and mortality expected in or after 2009. We 
therefore defined the years 2009 onwards as the post-crisis period, consistent with established 
usage. However, we recognise that the timing oif the crisis differed across countries.
2
    
Results 
Overall, amenable and other mortality declined in all EU countries between 2000 and 2015. For 
amenable mortality, the average pace of decline varied between and annual percentage change 
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(APC) of 0.4 in Lithuania to 5.6 in Ireland for males and between 1.8 in Lithuania and Italy to 5.0 in 
Ireland for females. The pace of decline of other mortality ranged from APC 1.2 in Bulgaria, Greece 
and Lithuania to 3.6 in Croatia and Slovenia for males and from 0.5 in Portugal to 4.6 in Cyprus for 
females. With the exception of Cyprus (females) and Lithuania (males), amenable mortality declined 
faster, on average, than other mortality (Table 1).   
[Table 1 about here ]  
Since 2000, 30 Joinpoints in 18 countries were identified across both genders in amenable mortality 
trends. Most of these were related to amenable mortality displaying either more favourable, or a 
similar direction of change compared to other mortality (Appendix 2). There were only four 
instances of reversals in amenable mortality coinciding with the onset of the economic crisis (from 
decreases to 0 APC change or increases), against a background of a continued fall in other mortality. 
These were observed for females in Estonia (-4.5 APC in 2005-2012 to 0 APC in 2012-2014) and 
Slovenia (-4.2 in 2000-2013 to 0.7 in 2013-2015), as well as males and females in Greece (males: -2.9 
APC in 2000-2010 to 0 APC in 2010-2013; females; -3.5 APC in 2000-2010 to 0.1 APC in 2010-2013) 
(Figure 1). 
[ Figure 1 about here ]   
To better understand drivers of amenable deaths behind the post-crisis reversals, we performed 
Joinpoint analysis by cause of death for Estonia, Greece and Slovenia, for males and females (Table 
2).  
[ Table 2 about here ]  
Observed reversals in female amenable mortality in Estonia was attributable, mainly, to a large 
relative increase in deaths from infectious diseases after 2012, on top off an underlying increasing 
trend in amenable deaths from respiratory conditions and treatable cancers since 2007. Among 
males, there was a small increase in amenable respiratory deaths, from 2011. A similar picture is 
seen in Slovenia, where a reversal in amenable mortality in females can be attributed to an increase 
in deaths from infectious diseases after 2010, accompanied by underlying slowing in the rate of 
decrease of amenable deaths from ischaemic heart disease after 2007, while the rate of reduction in 
other amenable causes remained consistent. Unlike in Estonia, there was a similar pattern among 
males in Slovenia, with a reversal in amenable deaths from infectious diseases after 2012, but also 
an underlying reduction in the pace of decline in deaths from ischaemic heart disease and 
respiratory conditions. Further examination of trends of infectious diseases found substantial recent 
Page 4 of 17
http://mc.manuscriptcentral.com/ejph
Manuscripts submitted to European Journal of Public Health
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
rises in deaths from sepsis in both countries, although absolute numbers remain small (data not 
shown).  
In Greece, amenable mortality reversed for males and females in 2010. This was driven by a complex 
set of changes, which also differed between males and females. Thus, the observed changes 
occurred against the background of small, but sustained increases in selected amenable causes of 
death since 2000. These included mortality from amenable infectious diseases, and from digestive 
and respiratory conditions among males and females, rose at a pace of between 1 and 3 per cent per 
year between 2000 and 2013. In addition, males experienced sustained increases in mortality from 
amenable cancers (APC 0.6%) and diabetes (APC 1.1%) from 2000 onwards. Mortality from stroke 
fell throughout the entire observation period but we observed a significant deceleration of the pace 
of decline that coincided with the crisis (-7% in 2000-2010 to -0.8% APC in 2010-2013 in females and 
-6.6% in 2005-2010 to -0.2% in 2010-2013 in males). Reversals in mortality were observed for males 
for amenable perinatal and congenital conditions, which had been declining until 2007 (APC -8% in 
2000-2007 to 0.3% in 2007-2013) and the remaining amenable causes of death (APC -7.2% in 2000-
2004 to 2.4% in 2004-2013).  
Discussion 
This study found wide variations in both levels and pace of change in amenable mortality over time 
across EU member states. While rates have, overall, declined, some countries experienced reversals 
in recent years, at least in the short-term. These are still fairly small in Estonia, Greece and Slovenia, 
but these countries have seen no increase in other mortality, suggesting that while overall 
population health is improving, health services may have experienced some challenges. However, 
observed trends have to be interpreted with caution as they affected males and females differently. 
In any case, a significant reversal in what has been a very long-term decline in mortality in any 
country should be a cause of concern, requiring further investigation.    
Amenable mortality, as used in this study, plays a dual role. First, it is one of the few existing 
indicators, which provides an initial assessment of the potential contribution of health services to 
population health. Second, as the outcome is deaths, it can help understand the impact of health 
system change. While it is not possible, with aggregate data, to trace specific policies and actions 
affecting service delivery that lead to amenable deaths, it is known that the global financial crisis was 
associated with reduced access to care in multiple countries across the EU, particularly among more 
vulnerable groups.
18
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Trends in amenable mortality in Estonia, Greece and Slovenia present a complex picture. First, while 
total amenable mortality in Estonia and Slovenia has reversed only in women after the crisis, cause-
specific data show that men have also been affected, although to a lesser extent. In Estonia, the rise 
in amenable mortality in females was driven partially by an increase in mortality from infectious 
diseases, but this was not replicated in males. At the same time, rise in deaths from respiratory 
conditions seen across both genders was more pronounced in males, while both sexes experienced 
rise in mortality from other amenable conditions throughout the period. In Slovenia, the rise in 
deaths from infectious diseases was sharp in both genders in recent years, but only in females did it 
result in a pronounced change of direction in overall amenable mortality. It is important to note that 
deaths from infectious disease present a very small proportion of total amenable mortality, and 
absolute numbers are particularly low when disaggregated by gender in countries with small 
populations, such as Estonia and Slovenia. The increase in mortality from infectious diseases in both 
countries was driven by a rise in deaths from septicaemia, a trend seen in other European countries, 
such as the Czech Republic 
19
 and Serbia 
20
. Explanations of these trends are complex, including 
population ageing and rising prevalence of complications of chronic diseases, while in Serbia the 
increase corresponded with the onset of the economic crisis. Suhrcke et al. suggested various 
mechanisms by which economic crises can affect communicable disease control, such as through 
compromising the health of vulnerable population groups and placing additional pressures on health 
systems facing budgetary problems.
21
 However, the precise manifestations depended on the 
underlying epidemiological situation. 
The effects of the measures imposed on Greece following the global financial crisis, including 
sustained reductions in public spending on health services, together with the broader impact of the 
crisis on population health, have been detailed elsewhere.
22-25
 This body of research has shown that 
while crisis in itself can pose real threats to health, particularly of vulnerable people, through 
unemployment and loss of income, the austerity measures to health system exacerbate the issue 
and further limit access to and quality of health care services. In terms of mortality outcomes, tThere 
is some limited research on selected causes of death, such as suicides
26
, cardiovascular diseases and 
cancers, all of which show unfavourable trends since the start of the crisis. Our analysis of amenable 
mortality points to more long-standing challenges that people in Greece might have experienced 
regarding access to and effectiveness of health care which were present even before the economic 
crisis. Thus, we found small but steady increases in a number of amenable conditions from 2000 
onwards, suggesting that the crisis might have exposed systemic problems in the Greek health 
system which eventually led to an overall reversal in amenable mortality in Greece. Available 
evidence has documented fragmentation of coverage, a poorly developed primary care system, and 
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lack of referral systems, along with poorly coordinated care across the care pathway.
27
 These 
underlying challenges will have been exacerbated by the changes imposed by the economic crisis, 
including a cut of 40% of overall public spending on health between 2009 and 2013
1
, coupled with 
exclusion of a large proportion of population from health coverage due to rising unemployment, as 
well as the sharply rising unmet medical need
28
 observed since the start of the crisis. Others have 
suggested that an increase in mortality at older ages in Greece in 2011-12 may be linked to problems 
accessing care
29
, while one study reported an increase in deaths due to adverse events associated 
with medical treatment
30
.   Consequently, deterioration in amenable mortality, along with other 
health outcomes, is not unexpected.  
From a broader perspective, our findings suggest that amenable mortality may be a relatively 
insensitive indicator of the impact of the economic crisis on the quality of healthcare. This is partly 
due to the inherent limitations of amenable mortality indicator overall: setting the widely accepted 
age limit at 75 years to minimise issues with coding of multi-morbidity excludes large number of 
potentially amenable deaths in older people, reduces the potential of detecting significant change 
when low levels have been achieved, and increases chances of random year-on-year fluctuations in 
specific amenable causes due to small numbers. In addition, amenable mortality captures only 
deaths thus missing the impacts on morbidity. Moreover, given recent advances in health care, there 
is a need to keep the list of amenable causes under continuing review to accurately reflect the 
current capability of healthcare to prevent deaths. Concerning studying the impacts of the economic 
crisis, another set of limitations arises from the problem of defining the “crisis”, given how the range 
of possible economic indicators (Gross domestic product, employment, housing repossessions etc.) 
varied across countries, as did the extent to which cuts were directed at healthcare specifically, and 
differences in the ability of health system to withstand economic fluctuations. Finally, data 
availability and timeliness remains problematic, with many years of detailed mortality data missing 
even for high-income countries, leading to shorter or even interrupted timelines.    
In summary, this study adds to the growing body of evidence showing that amenable mortality 
continues to decline across Europe. At the same time, it highlights increases of deaths from 
infectious diseases which should either be treatable or preventable in a small number of countries, 
and calls for investigation of the factors underlying these developments. Other causes for concern 
include respiratory conditions, as well as the sudden slowdown in the decline in mortality from 
stroke in Greece. Amenable mortality is a useful tool to highlight the presence of potential concerns 
about health systems performance, but its ability to detect the impact of changes in public spending 
on health care on the outcomes achieved by an individual health system is limited.   
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Key points:  
- Amenable mortality has declined in all EU countries between 2000 and 2015, however 
Estonia, Greece and Slovenia have seen a reversal in previously favourable trends in recent 
years. 
- Individual causes of death contributing to the reversal in amenable mortality suggest a 
complex picture but the rise in mortality from infectious diseases in at least 3 countries calls 
for further investigation. 
- Mortality trends in Greece show a sustained rise in deaths from a number of amenable 
causes, which predated the crisis, while progress stalled in reducing deaths from stroke 
corresponding to the onset of health expenditure cuts.  
- The use of amenable mortality to detect the impact of economic fluctuations on health 
system performance is limited, due to delayed data availability, ever-reducing scope for 
improvement, and the focus on death rather than other less adverse health outcomes.    
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Table 1. Overall change in amenable and non-amenable mortality (APC) since 2000 
 
Amenable mortality Other mortality 
 
males females males females 
Austria -4.4 -3.5 -1.7 -0.9 
Belgium -3.9 -3.0 -2.0 -0.9 
Bulgaria -2.0 -2.8 -1.2 -2.2 
Croatia -3.7 -4.5 -3.6 -3.2 
Cyprus -4.0 -4.3 -2.9 -4.6 
Czech Republic -3.4 -4.0 -2.0 -1.6 
Denmark -4.3 -4.5 -2.5 -2.7 
Estonia -4.5 -4.6 -2.9 -3.1 
Finland -4.3 -3.6 -1.8 -1.0 
France -3.6 -2.6 -2.2 -1.3 
Germany -3.6 -2.9 -1.9 -1.1 
Greece -2.3 -2.7 -1.2 -1.5 
Hungary -2.8 -2.9 -2.3 -1.4 
Ireland -5.6 -5.0 -3.0 -2.4 
Italy -2.1 -1.8 -2.0 -0.9 
Latvia -2.7 -2.8 -1.9 -1.8 
Lithuania -0.4 -1.8 -1.2 -1.0 
Luxembourg -4.4 -3.8 -3.2 -2.2 
Malta -4.8 -4.4 -2.7 -2.6 
Netherlands -4.6 -3.3 -2.7 -1.2 
Poland -3.5 -3.7 -1.7 -1.4 
Portugal -4.5 -2.5 -3.3 -0.5 
Romania -2.4 -3.2 -1.5 -2.1 
Slovakia -3.4 -3.4 -2.1 -1.7 
Slovenia -4.5 -3.6 -3.6 -2.9 
Spain -3.3 -3.2 -2.6 -1.9 
Sweden -3.5 -2.9 -1.7 -1.2 
United Kingdom -4.9 -4.2 -2.2 -1.6 
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Table 2. Changes in amenable mortality by cause in Estonia, Greece and Slovenia 
  Estonia Greece Slovenia 
  Males Females Males Females Males Females 
Cause Segments APC Segments APC Segments APC Segments APC Segments APC Segments APC 
Infectious diseases 2000-2014 -10.6* 2000-2012 -15.7* 2000-2013 2.9* 2000-2013 2.5 2000-2006 2.7 2000-2006 7.7 
    
 
2012-2014 91.4 
    
2006-2012 -26.0* 2006-2010 -32.6 
    
 
  
 
2012-2015 20.4 2010-2015 15.9 
Treatable cancers 2000-2014 -0.9* 2000-2007 -3.6* 2000-2013 0.6 2000-2013 -0.6* 2000-2015 -1.4* 2000-2015 -2.3* 
      2007-2014 0.0                 
Diabetes 2000-2014 -0.2 2000-2014 -5.9 2000-2013 1.1 2000-2013 -1.7 - - - - 
                          
IHD (50% amenable) 2000-2002 0.1 2000-2014 -9.6* 2000-2013 -2.7* 2000-2013 -3.9* 2000-2006 -6.2* 2000-2007 -9.0* 
  2002-2014 -7.0*             2006-2015 -2.2* 2007-2015 -0.7 
Stroke 2000-2005 -5.8* 2000-2014 -11.2* 2000-2005 -3.5* 2000-2010 -7.0* 2000-2015 -5.7* 2000-2015 -5.2* 
  2005-2014 -11.9* 
 
  2005-2010 -6.6* 2010-2013 -0.8   
 
  
          2010-2013 -0.2             
Respiratory disorders 2000-2011 -10.6* 2000-2007 -14.7* 2000-2013 1.3 2000-2013 1.9 2000-2004 2.8 2000-2015 -8.2* 
  2011-2014 23.4 2007-2014 4.6 
 
2004-2007 -22.0 
 
  
    
  
  
    
2007-2015 -7.0* 
 
  
Digestive disorders 2000-2014 -4.2* 2000-2014 -3.3* 2000-2013 1.1 2000-2013 1.8 2000-2015 -9.2* 2000-2015 -8.0* 
                          
Perinatal and congenital 2000-2014 -7.4* 2000-2014 -8.0* 2000-2007 -8.0* 2000-2013 -5.2* 2000-2015 -4.8* 2000-2015 -5.9* 
          2007-2013 0.3             
Other amenable causes 2000-2009 10.3* 2000-2014 5.3* 2000-2004 -7.2 2000-2013 -2.1* 2000-2015 -4.2* 2000-2015 -4.0* 
  2009-2014 0.0     2004-2013 2.4*             
* Significant at p<0.05; Note: In Slovenia, the number of deaths from diabetes is 0 for some years, therefore the cause has been excluded from joinpoint 
regression analysis 
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Figure 1. Amenable mortality trends (APC) in Estonia, Greece and Slovenia, 2000-2015 
 
 
Estonia, males Estonia, females 
Greece, males Greece, females 
Slovenia, males Slovenia, females 
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Online Supplement. Appendix 1. List of amenable causes of deaths  
Amenable causes of death Age ICD-10 code 
Infectious diseases 
Intestinal infections 
Tuberculosis 
Other infections (tetanus, diphtheria septicaemia, poliomyelitis) 
Whooping cough 
Measles 
 
Treatable cancers 
Colon and rectum 
Skin 
Breast 
Cervical and uterus 
Testis 
Hodgkin’s disease 
Leukaemia 
 
Diabetes 
Ischaemic heart disease (50% of deaths) 
Cerebrovascular disease 
 
Respiratory diseases 
Influenza 
Pneumonia 
Other respiratory conditions 
 
Digestive diseases 
Peptic ulcer 
Appendicitic 
Abdominal hernia 
Cholelithiasis and cholecystitis 
 
Perinatal deaths 
 
Other amenable conditions 
Diseases of thyroid 
Epilepsy 
Chronic rheumatic heart disease 
Hypertensive disease 
Nephritis and nephrosis 
Benign prostatic hyperplasia 
Misadventures to patients 
Maternal deaths 
Congenital cardiovascular anomalies 
 
0-14 
0-74 
0-74 
0-14 
1-14 
 
 
0-74 
0-74 
0-74 
0-44 
0-74 
0-74 
0-44 
 
0-49 
0-74 
0-74 
 
 
0-74 
0-74 
1-14 
 
 
0-74 
0-74 
0-74 
0-74 
 
0-74 
 
 
0-74 
0-74 
0-74 
0-74 
0-74 
0-74 
0-74 
0-74 
0-74 
 
A00-09 
A15-19, B90 
A36, A35, A80 
A37 
B05 
 
 
C18-21 
C44 
C50 
C53-55 
C62 
C81 
C91-95 
 
E10-14 
I20-25 
I60-69 
 
 
J10-11 
J12-18 
J00-09, J20-99 
 
 
K25-27 
K35-38 
K40-46 
K80-81 
 
P00-96, A33 
 
 
E00-07 
G40-41 
I05-09 
I10-13, I15 
N00-07, N17-19, 
N25-27 
Y60-69, Y83-84 
O00-99 
Q20-28 
Source: Adapted from Nolte and McKee
7
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Online Supplement. Appendix 2. Joinpoint regression results for 28 EU member states, 2000-2015 
(or latest available) 
  Males Females 
Country Cause 
No of 
joinpoints Segments APC 
No of 
joinpoints Segments APC 
Austria amenable 1 2000-2005 -6.8* 1 2000-2008 -4.7* 
2005-2014 -3* 2008-2014 -1.9* 
other 0 2000-2014 -1.7* 1 2000-2007 -1.7* 
2007-2014 -0.1 
Belgium amenable 0 2000-2014 -3.9* 0 2000-2014 -3* 
other 2 2000-2006 -2.9* 2 2000-2006 -1.9* 
2006-2012 -0.7 2006-2012 0.6 
2012-2014 -3.3 2012-2014 -2.6 
Bulgaria amenable 0 2000-2013 -2* 0 2000-2013 -2.8* 
other 1 2000-2011 -0.8* 2 2000-2007 -2.4* 
2011-2013 -3.4* 2007-2011 -0.6 
  2011-2013 -4.8* 
Croatia amenable 0 2000-2015 -3.7* 1 2000-2002 -13.8* 
2002-2015 -2.9* 
other 1 2000-2002 -12.7* 1 2000-2002 -11.5* 
2002-2015 -2.1* 2002-2015 -1.8* 
Cyprus amenable 0 2004-2014 -4* 0 2004-2014 -4.3* 
other 0 2004-2014 -2.9* 0 2004-2014 -4.6* 
Czech Republic amenable 1 2000-2011 -3.8* 0 2000-2015 -4* 
2011-2015 -2.1* 
other 0 2000-2015 -2* 0 2000-2015 -1.6* 
Denmark amenable 1 2000-2003 -0.4 2 2000-2002 -1.3 
2003-2014 -5.3* 2002-2010 -4.5* 
2010-2014 -6* 
other 0 2000-2014 -2.5* 0 2000-2014 -2.7* 
Estonia amenable 0 2000-2014 -4.5* 2 2000-2005 -6.5* 
2005-2012 -4.5* 
2012-2014 0 
other 2 2000-2007 -1.2* 2 2000-2007 -2.2* 
2007-2010 -7.9* 2007-2010 -6.6 
2010-2014 -2.2 2010-2014 -2.1 
Finland amenable 1 2000-2006 -5.1* 0 2000-2014 -3.6* 
2006-2014 -3.7* 
other 1 2000-2008 -1.1* 0 2000-2014 -1* 
2008-2014 -2.7* 
France amenable 0 2000-2013 -3.6* 0 2000-2013 -2.6* 
other 1 2000-2007 -2.7* 2 2000-2003 -0.7 
2007-2013 -1.6* 2003-2006 -3.1* 
2006-2013 -0.8* 
Germany amenable 1 2000-2011 -4* 1 2000-2010 -3.4* 
2011-2014 -1.8 2010-2014 -1.7* 
other 1 2000-2007 -2.8* 1 2000-2007 -2.1* 
2007-2014 -1* 2007-2014 0 
Greece amenable 1 2000-2010 -2.9* 1 2000-2010 -3.5* 
2010-2013 0 2010-2013 0.1 
other 0 2000-2013 -1.2* 1 2000-2006 -3.1* 
2006-2013 -0.2 
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Hungary amenable 0 2000-2015 -2.8* 1 2000-2007 -3.7* 
2007-2015 -2.2* 
other 1 2000-2008 -1.3* 0 2000-2015 -1.4* 
2008-2015 -3.3* 
Ireland amenable 0 2000-2013 -5.6* 1 2000-2002 -9.5* 
2002-2013 -4.1* 
other 0 2000-2013 -3* 1 2000-2006 -3.3* 
2006-2013 -1.6* 
Italy amenable 0 2006-2012 -2.1* 0 2006-2012 -1.8* 
other 1 2006-2010 -2.7* 0 2006-2012 -0.9* 
2010-2012 -0.7 
Latvia amenable 1 2000-2006 -0.7 1 2000-2005 -1.1 
2006-2014 -4.2* 2005-2014 -3.8* 
other 1 2000-2006 0.3 1 2000-2006 0.4 
2006-2014 -3.5* 2006-2014 -3.4* 
Lithuania amenable 2 2000-2007 2.4* 1 2000-2007 0 
2007-2010 -5.4 2007-2015 -3.3* 
2010-2015 -1.1 
other 1 2000-2007 1.6* 2 2000-2007 1.4* 
2007-2015 -3.5* 2007-2010 -5.6 
2010-2015 -1.5* 
Luxembourg amenable 0 2000-2014 -4.4* 0 2000-2014 -3.8* 
other 0 2000-2014 -3.2* 0 2000-2014 -2.2* 
Malta amenable 0 2000-2014 -4.8* 0 2000-2014 -4.4* 
other 0 2000-2014 -2.7* 0 2000-2014 -2.6* 
Netherlands amenable 1 2000-2008 -5.4* 0 2000-2015 -3.3* 
2008-2015 -3.6* 
other 2 2000-2002 -2.1 2 2000-2003 -0.2 
2002-2008 -3.9* 2003-2007 -3.5* 
2008-2015 -1.8* 2007-2015 -0.4* 
Poland amenable 1 2000-2012 -2.9* 2 2000-2002 -5.2* 
2012-2014 -7.1* 2002-2012 -3.1* 
2012-2014 -5.1* 
other 2 2000-2002 -2.6 1 2000-2002 -3.7 
2002-2007 -0.4 2002-2014 -1* 
2007-2014 -2.3* 
Portugal amenable 0 2007-2014 -4.5* 0 2007-2014 -2.5* 
other 1 2007-2014 -3.3* 1 2007-2012 -2.8* 
2012-2014 5.6* 
Romania amenable 1 2000-2002 3.5 1 2000-2002 2.2 
2002-2015 -3.2* 2002-2015 -4* 
other 0 2000-2015 -1.5* 0 2000-2015 -2.1* 
Slovakia amenable 1 2000-2009 -2.8* 0 2000-2014 -3.4* 
2009-2014 -4.5* 
other 2 2000-2003 -2.5* 1 2000-2007 -0.7* 
2003-2006 0.2 2007-2014 -2.7* 
2006-2014 -2.8* 
Slovenia amenable 0 2000-2015 -4.5* 1 2000-2013 -4.2* 
2013-2015 0.7 
other 0 2000-2015 -3.6* 0 2000-2015 -2.9* 
Spain amenable 0 2000-2014 -3.3* 0 2000-2014 -3.2* 
other 1 2000-2003 -1.7* 0 2000-2014 -1.9* 
2003-2014 -2.8* 
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Sweden amenable 1 2000-2011 -4.1* 0 2000-2015 -2.9* 
2011-2015 -1.8* 
other 2 2000-2004 -1.3* 0 2000-2015 -1.2* 
2004-2013 -2.3* 
2013-2015 0.4 
United Kingdom amenable 0 2001-2013 -4.9* 0 2001-2013 -4.2* 
other 0 2001-2013 -2.2* 0 2001-2013 -1.6* 
* Significant at p<0.05 
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